In very close proximity to the Swiss Federal Institute of Technology (ETH), the University and Zurich University Hospital, a science park for life science companies and institutions has developed in the last two decades, which has now acquired both national and international significance. Based in and around what was once the site of the company Schweizerische Wagons- und Aufzügefabrik AG, with a base area of 55,000 m2, the park now hosts 45 companies and many academic institutions representing a healthy mix of young start-ups and global companies as well as university clinics, institutes, and research groups.
As part of the Technopark Alliance, the Bio-Technopark supports start-up entrepreneurs, provides them with made-to-measure infrastructure, and promotes the exchange of ideas between all of the life science organizations based there.
The Bio-Technopark has gained a great deal of respect, thanks in part to the successful sales of start-ups to major corporations and international companies such as Roche, Novartis, J&J, GSK, Pfizer, Thermo Fisher Scientific, Cell Medica, Sunstar and Heptares. Considerable financing rounds, the initial public offering of Molecular Partners, and successful product developments have also made headlines. Today, the life science organizations on the site employ more than 1,200 people.
Mario Jenni, Co-founder & CEO
- Ernst Hafen, PhD (President), Professor at the Institute of Molecular Systems Biology, ETH Zurich
- Danielle Spichiger (Vice-President), Head Life Sciences, Business and Economic Development Division, Canton of Zurich
- Harry Welten (Treasurer), Chairman of BiognoSYS AG, board member of multiple start-ups
- Philippe Fuchs, lawyer
- Walter Krummenacher, CEO of Gewerbe- und Handelszentrums Schlieren AG
- Michael Salzmann, PhD, COO of Neurimmune AG
- Albert Schweizer, Divisional Head of Properties & Location Promotion, Municipality of Schlieren